Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4146-4153
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4146
Table 1 Comparison of the positive expression rates of human papillomavirus-DNA and human papillomavirus E6/E7 mRNA in each group (%)
GroupExample numberHPV E6/E7 mRNAHPV (PCR-reverse point hybridization)
PositiveNegativePositiveNegative
CINI level4813 (27.1)35 (72.9)15 (31.3)33 (68.7)
CIN II level3124 (77.4)7 (22.6)21 (67.7)10 (32.3)
CIN III level1612 (75.0)4 (25.0)11 (68.7)5 (31.3)
Squamous or adenocarcinoma53 (18.8)2 (12.5)4 (25.0)1 (6.3)
χ223.48314.669
P value< 0.0010.002
Table 2 Results of the univariate analysis affecting the diagnosis of cervical intraepithelial neoplasia high-grade lesions (%)
ProjectCIN grade (n = 52)CIN grade I (n = 48)χ2P value
Age0.4950.482
    ≥ 4515 (28.8)17 (35.4)
    < 4537 (71.2)31 (64.6)
Gravidity0.0310.861
    ≥ 216 (30.8)14 (29.2)
    < 236 (69.2)34 (70.8)
Parity0.4950.482
    ≥ 215 (28.8)17 (35.4)
    < 237 (71.2)31 (64.6)
HPV (PCR reverse-dot hybridization)14.408< 0.001
    Positive36 (69.2)15 (31.3)
    Negative16 (30.8)33 (68.7)
HPV E6/E7 mRNA22.960< 0.001
    Positive39 (75.0)13 (27.1)
    Negative13 (25.0)35 (72.9)
Table 3 Results of logistic factor analysis
MetricβSEWaldsP valueOR95%CI
HPV (PCR reverse-dot hybridization)-0.1630.5110.1020.0071.8501.312-2.312
HPV E6/E7 mRNA0.6300.5100.5230.0221.8771.690-5.120
Table 4 Effect of positive human papilloma virus E6/E7 mRNA expression on the development of disease in patients with cervical intraepithelial neoplasia grade I (%)
HPV E6/E7 mRNAExample numberCIN I levelCIN II level
Positive134 (30.8)9 (69.2)
Negative3525 (71.4)10 (28.6)
χ26.553
P value0.010